Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GRAM Appoints Business Development VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

GRAM Appoints Business Development VP

Industry veteran David Powell has held leadership roles at Abbott, Hospira, and Pfizer

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Grand River Aseptic Manufacturing (GRAM), has appointed industry veteran David Powell to its executive team as vice president of business development.


 David Powell
“I am honored to join the GRAM family. The quality focus, impressive facility expansion, and company culture stand out. It’s a privilege to be part of this team,” said David. “I look forward to educating the biopharmaceutical industry on the quality processes, capabilities, and customer service found at GRAM.”

Prior to joining the company, David held leadership roles at Abbott, Hospira, and most recently, Pfizer. As Pfizer’s senior director, Development Services and Commercial Accounts, he headed the global Development Services and Commercial Accounts organizations of the CentreOne contract development and manufacturing business, including accountability for customer management. David has led personnel in Europe, India, Japan and Australia.  

“I am thrilled to welcome Dave to our team as GRAM is ready to embark upon a significant expansion.  Dave has a strong passion for pharmaceutical manufacturing with a focus on quality.  His organization leadership and commercial-scale project expertise are invaluable as we continue to grow,” said Tom Ross, president and chief executive officer. “I look forward to working with Dave and seeing all he will accomplish in leading our business development efforts. GRAM’s continued focus on exceptional quality, superior customer service and excellent technical competency will enable Dave to build upon our amazing growth.”

Expected to open in 2020, GRAM’s 60,000 sq.-ft. Butterworth facility will provide additional manufacturing capacity and high quality solutions for customers with biologic and small molecule projects. The new facility will be GRAM’s fifth location in Grand Rapids.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters